ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Testosterone Replacement in Prostate Cancer Survivors
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 255119" data-attributes="member: 13851"><p><em><strong>*<em>Finally, Dr. Valderrabano speaks about <u>his research trial focused on giving TRT to prostate cancer survivors who have hypogonadism</u>. His patient cohort includes prostate cancer patients who have a low risk of disease recurrence are at least 2 years into remission, have normal PSA levels, and are on no other hormone therapy treatments. His main outcomes are physical and sexual health. He also explains his data collection methods and collaboration with other institutions.</em></strong></em></p><p></p><p>[URL unfurl="true"]https://www.excelmale.com/forum/threads/testosterone-treatment-of-prostate-cancer-survivors-spirit-trial.26161/[/URL]</p><p></p><p></p><p><strong>Methods. </strong><em>Surviving Prostate Cancer while Improving the Quality of Life through Rehabilitation with Testosterone Trial (The SPIRIT Trial) is a randomized, placebo-controlled, double-blind, parallel-group trial in 142 men, >40 years, who have undergone radical prostatectomy for organ-confined prostate cancer, Gleason score <7 (3+4), Stage pT2, N0, M0 lesions and have symptomatic testosterone deficiency and undetectable PSA for >2 years after surgery. <strong>Eligible participants are randomized to weekly intramuscular injections of 100-mg testosterone cypionate or placebo for 12 weeks and followed for another 12 weeks.</strong> The primary endpoint is a change from baseline in sexual activity. Secondary outcomes include a change in sexual desire, erectile function, energy, lean and fat mass, and physical and cognitive performance. Safety is assessed by monitoring PSA, lower urinary tract symptoms, hemoglobin, and adverse events.</em></p></blockquote><p></p>
[QUOTE="madman, post: 255119, member: 13851"] [I][B]*[I]Finally, Dr. Valderrabano speaks about [U]his research trial focused on giving TRT to prostate cancer survivors who have hypogonadism[/U]. His patient cohort includes prostate cancer patients who have a low risk of disease recurrence are at least 2 years into remission, have normal PSA levels, and are on no other hormone therapy treatments. His main outcomes are physical and sexual health. He also explains his data collection methods and collaboration with other institutions.[/I][/B][/I] [URL unfurl="true"]https://www.excelmale.com/forum/threads/testosterone-treatment-of-prostate-cancer-survivors-spirit-trial.26161/[/URL] [B]Methods. [/B][I]Surviving Prostate Cancer while Improving the Quality of Life through Rehabilitation with Testosterone Trial (The SPIRIT Trial) is a randomized, placebo-controlled, double-blind, parallel-group trial in 142 men, >40 years, who have undergone radical prostatectomy for organ-confined prostate cancer, Gleason score <7 (3+4), Stage pT2, N0, M0 lesions and have symptomatic testosterone deficiency and undetectable PSA for >2 years after surgery. [B]Eligible participants are randomized to weekly intramuscular injections of 100-mg testosterone cypionate or placebo for 12 weeks and followed for another 12 weeks.[/B] The primary endpoint is a change from baseline in sexual activity. Secondary outcomes include a change in sexual desire, erectile function, energy, lean and fat mass, and physical and cognitive performance. Safety is assessed by monitoring PSA, lower urinary tract symptoms, hemoglobin, and adverse events.[/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Testosterone Replacement in Prostate Cancer Survivors
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top